Immunotherapy discontinuation — how, and when? Data from melanoma as a paradigm
Caroline Robert, Aurélien Marabelle, Hugo Herrscher, Caroline Caramella, Pascal Rouby, Karim Fizazi, Benjamin Besse
Topics & Concepts
MedicineDiscontinuationImmunotherapyMelanomaMEDLINEOncologyInternal medicineIntensive care medicineCancer researchCancerLawPolitical scienceCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research